NEULANDLAB - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 4.0
✅ Positive
The stock has demonstrated significant growth over the past quarter, with a remarkable 666% increase in Qtr Profit Variance and EPS reaching 283₹. FII and DII holdings are increasing, indicating growing investor confidence.
⚠️ Limitation
Despite strong recent performance, the high P/E ratio of 68.0 suggests potential overvaluation, and the PEG Ratio of 2.26 further highlights this concern. Fluctuations in commodity prices could impact future profitability.
📉 Company Negative News
None found
📈 Company Positive News
None found
🏭 Industry
The pharmaceutical sector is currently experiencing growth driven by increasing healthcare expenditure and demand for generic drugs. Neuland Laboratories operates within the specialty pharmaceuticals segment, focusing on APIs (Active Pharmaceutical Ingredients), which often commands higher margins compared to branded generics.
🧾 Conclusion
Based on the chart patterns, the stock is trending upwards with a clear upward sloping DMA 50 and DMA 200, suggesting continued momentum. An optimal entry zone could be between 18,800 ₹ and 19,300 ₹, utilizing established resistance levels as potential stop-loss points at 19,800 ₹. Overall, the stock exhibits strong positive signals warranting a ‘Buy’ recommendation for short to medium term traders.